Experimental Blood Test Shows Promise in Early Detection of Pancreatic Cancer
- Published:
- First detected:
Insights by Echo AI
A new experimental blood test, Panxeon, has shown promising results in detecting pancreatic cancer in its early stages. Led by researchers at City of Hope, the test detected approximately 87% of cases in stages I and II, when the tumor usually does not show symptoms. This is significant because pancreatic cancer is typically caught in its latest stages, making it difficult to treat. The test combines three biomarkers into one risk score, using an artificial intelligence algorithm. It is not yet a replacement for imaging techniques but could serve as a complementary tool for high-risk individuals.
Source coverage
5
records merged
2
2 unique
0
0 unique
3
3 unique
5 Sources
Un test experimental de sangre abre la puerta a detectar el cáncer de...
Un test experimental de sangre abre la puerta a detectar el cáncer de...
Blood test shows promise in detecting pancreatic cancer early—a 'Holy...
RT @medical_xpress: An investigational blood test detected stage 1 and...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
